Insider · CIK 0001823742
Louis Todd Borgmann
Files at CLMT (Calumet, Inc. /DE). First filing -, latest -.
Louis Todd Borgmann files SEC Form 4 as CEO at CLMT (Calumet, Inc. /DE). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Louis Todd Borgmann has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | CLMT Calumet, Inc. /DE | MOption exercise Common Stock, par value $0.01 per share | +107,428 | $0.00 | $0 | 371,170 | 15 d ago |
| Sep 25, 2026 | CLMT Calumet, Inc. /DE | FTax withholding Common Stock, par value $0.01 per share | -46,901 | $0.00 | $0 | 324,269 | 15 d ago |
| Sep 25, 2026 | CLMT Calumet, Inc. /DE | MOption exercise Restricted Stock Unitderivative | -107,428 | $0.00 | $0 | 0 | 15 d ago |
| Mar 31, 2026 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitderivative | +7,173 | $0.00 | $0 | 7,173 | Apr 2, 2026 |
| Mar 31, 2026 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitsderivative | +2,391 | $0.00 | $0 | 2,391 | Apr 2, 2026 |
| Mar 9, 2026 | CLMT Calumet, Inc. /DE | MOption exercise Common Stock, par value $0.01 per share | +49,974 | $0.00 | $0 | 285,540 | Mar 11, 2026 |
| Mar 9, 2026 | CLMT Calumet, Inc. /DE | FTax withholding Common Stock, par value $0.01 per share | -21,798 | $0.00 | $0 | 263,742 | Mar 11, 2026 |
| Mar 9, 2026 | CLMT Calumet, Inc. /DE | MOption exercise Restricted Stock Unitderivative | -49,974 | $0.00 | $0 | 0 | Mar 11, 2026 |
| Feb 24, 2026 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitsderivative | +67,882 | $0.00 | $0 | 67,882 | Feb 26, 2026 |
| Feb 24, 2026 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitderivative | +64,102 | $0.00 | $0 | 64,102 | Feb 26, 2026 |
| Mar 31, 2025 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitderivative | +9,271 | $0.00 | $0 | 9,271 | Apr 2, 2025 |
| Mar 31, 2025 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitsderivative | +3,090 | $0.00 | $0 | 3,090 | Apr 2, 2025 |
| Mar 11, 2025 | CLMT Calumet, Inc. /DE | MOption exercise Common Stock, par value $0.01 per share | +114,120 | $0.00 | $0 | 285,533 | Mar 13, 2025 |
| Mar 11, 2025 | CLMT Calumet, Inc. /DE | FTax withholding Common Stock, par value $0.01 per share | -49,967 | $0.00 | $0 | 235,566 | Mar 13, 2025 |
| Mar 11, 2025 | CLMT Calumet, Inc. /DE | MOption exercise Restricted Stock Unitderivative | -114,120 | $0.00 | $0 | 0 | Mar 13, 2025 |
| Feb 25, 2025 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitderivative | +189,472 | $0.00 | $0 | 189,472 | Feb 27, 2025 |
| Nov 22, 2024 | CLMT Calumet, Inc. /DE | AGrant or award Common Stock, par value $0.01 per share | +10,000 | $21.78 | $218k | 171,413 | Nov 25, 2024 |
| Nov 21, 2024 | CLMT Calumet, Inc. /DE | SOpen-market sale Call Option (right to buy)derivative | -900 | $280.00 | $252k | 0 | Nov 25, 2024 |
Questions about Louis Todd Borgmann
Answered from the filings on this page, as of the latest one.
Is Louis Todd Borgmann buying or selling?
Louis Todd Borgmann has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Louis Todd Borgmann's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Louis Todd Borgmann has 0.
Where does Louis Todd Borgmann file Form 4?
Louis Todd Borgmann has filed Form 4 at CLMT (Calumet, Inc. /DE) as CHIEF EXECUTIVE OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.